Drug Delivery

Dec 11, 2015
By BioPharm International Editors
Researchers from Oregon State University develop a new three-drug delivery system for cancer treatment.
Dec 09, 2015
By BioPharm International Editors
Assembly Biosciences reported a successful clinical study validating the use of the Gemicel technology platform for the oral delivery of biologic medications.
Dec 04, 2015
The company plans to reformulate injectable products to make them into inhaled and intranasal medications.
Aug 26, 2015
The company announced plans to begin PIONEER, a Phase IIIa program comprising seven trials of approximately 8000 people with type 2 diabetes.
Aug 01, 2015
BioPharm International
Gene and cell therapies represent the next-generation treatments for a wide range of diseases, but one challenge in the development of these therapeutics is the controlled delivery to the targeted site to maximize expression or engraftment while limiting systemic exposure.
Aug 01, 2015
BioPharm International
Industry experts spoke to BioPharm International about the key considerations in the development of a drug-delivery device for a biologic drug, the importance of human factors engineering, the advantages of prefilled syringes, and the challenges in the manufacture of these devices.
Jul 23, 2015
By BioPharm International Editors
The Catalent Applied Drug Delivery Institute and AAPS recognize four groups for emerging scientific talent and academic excellence.
Jul 15, 2015
By BioPharm International Editors
Two companies have been fined a total of GBP550,000 for faulty insulin syringes, which contained no drug and caused the death of a diabetic patient.
Jul 15, 2015
By BioPharm International Editors
Mylan issued a voluntary withdrawal of calcium chloride intravenous infusion 10% w/v 10mL prefilled syringe due to difficulties in administration.
Jul 01, 2015
By BioPharm International Editors
The new facility expands the company’s commercial manufacturing capability at its Bend, Ore. site.
native1_300x100
lorem ipsum